PTX-sensitive and -insensitive synaptic modulation at the frog neuromuscular

Y. Sugiura, C. P. Ko

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Pharmacological manipulations were used to examine the role of G proteins in modulating synaptic transmission at the frog neuromuscular junction. Pertussis toxin (PTX, a G protein antagonist) increased end-plate potential (epp) amplitude but had no effect on the amplitude or frequency of miniature end-plate potentials. Mastoparan (a G protein agonist) decreased epp amplitude, while suramin (an antagonist) increased epp amplitude. The results suggest that PTX-sensitive G proteins tonically modulate synaptic transmission by reducing the amount of transmitter released in response to presynaptic action potentials. We also showed that endogenous ATP decreased transmitter release via P2 receptor in a PTX-insensitive manner. Thus, at least two distinct mechanisms regulate neuromuscular transmission; one is coupled to PTX-sensitive G proteins and the other is not. (C) 2000 Lippincott Williams and Wilkins.

Original languageEnglish (US)
Pages (from-to)3017-3021
Number of pages5
JournalNeuroReport
Volume11
Issue number13
StatePublished - Sep 11 2000

Fingerprint

GTP-Binding Proteins
Anura
Excitatory Postsynaptic Potentials
Synaptic Transmission
Miniature Postsynaptic Potentials
Suramin
Neuromuscular Junction
Pertussis Toxin
Action Potentials
Adenosine Triphosphate
Pharmacology

Keywords

  • Heterotrimeric G protein
  • Neuromuscular junctions (NMJ)
  • Pertussis toxin (PTX)
  • Presynaptic inhibition
  • Synaptic modulation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

PTX-sensitive and -insensitive synaptic modulation at the frog neuromuscular. / Sugiura, Y.; Ko, C. P.

In: NeuroReport, Vol. 11, No. 13, 11.09.2000, p. 3017-3021.

Research output: Contribution to journalArticle

Sugiura, Y & Ko, CP 2000, 'PTX-sensitive and -insensitive synaptic modulation at the frog neuromuscular', NeuroReport, vol. 11, no. 13, pp. 3017-3021.
Sugiura, Y. ; Ko, C. P. / PTX-sensitive and -insensitive synaptic modulation at the frog neuromuscular. In: NeuroReport. 2000 ; Vol. 11, No. 13. pp. 3017-3021.
@article{016643d99f37455e8614fb958fab7a2e,
title = "PTX-sensitive and -insensitive synaptic modulation at the frog neuromuscular",
abstract = "Pharmacological manipulations were used to examine the role of G proteins in modulating synaptic transmission at the frog neuromuscular junction. Pertussis toxin (PTX, a G protein antagonist) increased end-plate potential (epp) amplitude but had no effect on the amplitude or frequency of miniature end-plate potentials. Mastoparan (a G protein agonist) decreased epp amplitude, while suramin (an antagonist) increased epp amplitude. The results suggest that PTX-sensitive G proteins tonically modulate synaptic transmission by reducing the amount of transmitter released in response to presynaptic action potentials. We also showed that endogenous ATP decreased transmitter release via P2 receptor in a PTX-insensitive manner. Thus, at least two distinct mechanisms regulate neuromuscular transmission; one is coupled to PTX-sensitive G proteins and the other is not. (C) 2000 Lippincott Williams and Wilkins.",
keywords = "Heterotrimeric G protein, Neuromuscular junctions (NMJ), Pertussis toxin (PTX), Presynaptic inhibition, Synaptic modulation",
author = "Y. Sugiura and Ko, {C. P.}",
year = "2000",
month = "9",
day = "11",
language = "English (US)",
volume = "11",
pages = "3017--3021",
journal = "NeuroReport",
issn = "0959-4965",
publisher = "Lippincott Williams and Wilkins",
number = "13",

}

TY - JOUR

T1 - PTX-sensitive and -insensitive synaptic modulation at the frog neuromuscular

AU - Sugiura, Y.

AU - Ko, C. P.

PY - 2000/9/11

Y1 - 2000/9/11

N2 - Pharmacological manipulations were used to examine the role of G proteins in modulating synaptic transmission at the frog neuromuscular junction. Pertussis toxin (PTX, a G protein antagonist) increased end-plate potential (epp) amplitude but had no effect on the amplitude or frequency of miniature end-plate potentials. Mastoparan (a G protein agonist) decreased epp amplitude, while suramin (an antagonist) increased epp amplitude. The results suggest that PTX-sensitive G proteins tonically modulate synaptic transmission by reducing the amount of transmitter released in response to presynaptic action potentials. We also showed that endogenous ATP decreased transmitter release via P2 receptor in a PTX-insensitive manner. Thus, at least two distinct mechanisms regulate neuromuscular transmission; one is coupled to PTX-sensitive G proteins and the other is not. (C) 2000 Lippincott Williams and Wilkins.

AB - Pharmacological manipulations were used to examine the role of G proteins in modulating synaptic transmission at the frog neuromuscular junction. Pertussis toxin (PTX, a G protein antagonist) increased end-plate potential (epp) amplitude but had no effect on the amplitude or frequency of miniature end-plate potentials. Mastoparan (a G protein agonist) decreased epp amplitude, while suramin (an antagonist) increased epp amplitude. The results suggest that PTX-sensitive G proteins tonically modulate synaptic transmission by reducing the amount of transmitter released in response to presynaptic action potentials. We also showed that endogenous ATP decreased transmitter release via P2 receptor in a PTX-insensitive manner. Thus, at least two distinct mechanisms regulate neuromuscular transmission; one is coupled to PTX-sensitive G proteins and the other is not. (C) 2000 Lippincott Williams and Wilkins.

KW - Heterotrimeric G protein

KW - Neuromuscular junctions (NMJ)

KW - Pertussis toxin (PTX)

KW - Presynaptic inhibition

KW - Synaptic modulation

UR - http://www.scopus.com/inward/record.url?scp=0034637803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034637803&partnerID=8YFLogxK

M3 - Article

C2 - 11006986

AN - SCOPUS:0034637803

VL - 11

SP - 3017

EP - 3021

JO - NeuroReport

JF - NeuroReport

SN - 0959-4965

IS - 13

ER -